These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29462658)

  • 1. Affinity-based separation methods for the study of biological interactions: The case of peroxisome proliferator-activated receptors in drug discovery.
    Temporini C; Brusotti G; Pochetti G; Massolini G; Calleri E
    Methods; 2018 Aug; 146():12-25. PubMed ID: 29462658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors α and γ for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection.
    Temporini C; Pochetti G; Fracchiolla G; Piemontese L; Montanari R; Moaddel R; Laghezza A; Altieri F; Cervoni L; Ubiali D; Prada E; Loiodice F; Massolini G; Calleri E
    J Chromatogr A; 2013 Apr; 1284():36-43. PubMed ID: 23466198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.
    Mirza AZ; Althagafi II; Shamshad H
    Eur J Med Chem; 2019 Mar; 166():502-513. PubMed ID: 30739829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).
    Peraza MA; Burdick AD; Marin HE; Gonzalez FJ; Peters JM
    Toxicol Sci; 2006 Apr; 90(2):269-95. PubMed ID: 16322072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immobilized fusion protein affinity chromatography combined with HPLC-ESI-Q-TOF-MS/MS for rapid screening of PPARγ ligands from natural products.
    Zhu J; Yi X; Liu W; Xu Y; Chen S; Wu Y
    Talanta; 2017 Apr; 165():508-515. PubMed ID: 28153290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.
    Gardner OS; Dewar BJ; Graves LM
    Mol Pharmacol; 2005 Oct; 68(4):933-41. PubMed ID: 16020742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Ligand Screening Tool Using Full-Length Human Peroxisome Proliferator-Activated Receptor-Expressing Cell Lines to Ameliorate Metabolic Syndrome.
    Tachibana K; Ishimoto K; Takahashi R; Kadono H; Awaji T; Yuzuriha T; Tanaka T; Hamakubo T; Sakai J; Kodama T; Aoki S; Doi T
    Chem Pharm Bull (Tokyo); 2019; 67(3):199-202. PubMed ID: 30827999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of synthetic sphingolipid analogs as ligands for peroxisome proliferator-activated receptors.
    Tsuji K; Satoh S; Mitsutake S; Murakami I; Park JJ; Li Q; Chang YT; Chung SK; Igarashi Y
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1643-6. PubMed ID: 19237283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.
    Mansour M
    Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PPARs: structure, mechanisms of action and control. Note I].
    Filip-Ciubotaru F; Foia L; Manciuc C; Grigore C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):477-84. PubMed ID: 21870744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human peroxisome proliferator-activated receptors ligand binding domain-maltose binding protein fusion protein in Escherichia coli: a convenient and reliable method for preparing receptor for screening ligands.
    Li C; Tian M; Yuan Y; Zhou Q
    Assay Drug Dev Technol; 2008 Dec; 6(6):803-10. PubMed ID: 19090689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development.
    Hong F; Xu P; Zhai Y
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endogenous ligands for PPARs].
    Inoue H
    Nihon Rinsho; 2005 Apr; 63(4):578-83. PubMed ID: 15828223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.
    Tan CK; Zhuang Y; Wahli W
    Expert Opin Ther Targets; 2017 Mar; 21(3):333-348. PubMed ID: 28092722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors and their relevance to dermatology.
    Friedmann PS; Cooper HL; Healy E
    Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.
    Pirard B
    J Comput Aided Mol Des; 2003 Nov; 17(11):785-96. PubMed ID: 15072437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators.
    Zoete V; Grosdidier A; Michielin O
    Biochim Biophys Acta; 2007 Aug; 1771(8):915-25. PubMed ID: 17317294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.
    Ammazzalorso A; De Filippis B; Giampietro L; Amoroso R
    ChemMedChem; 2013 Oct; 8(10):1609-16. PubMed ID: 23939910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.